ETR:BAYN

Bayer Aktiengesellschaft (BAYN) Stock Price, News & Analysis

€28.96
+0.26 (+0.91%)
(As of 05/10/2024 ET)
Today's Range
€28.79
€29.27
50-Day Range
€25.87
€28.77
52-Week Range
€24.96
€54.95
Volume
3.66 million shs
Average Volume
N/A
Market Capitalization
$28.45 billion
P/E Ratio
N/A
Dividend Yield
0.38%
Price Target
N/A
BAYN stock logo

About Bayer Aktiengesellschaft Stock (ETR:BAYN)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

BAYN Stock Price History

BAYN Stock News Headlines

Bayer Aktie: Spannung vor Veröffentlichung des Quartalsberichts
1. Bundesliga: Bayer baut Serie auf 50 ungeschlagene Spiele aus
Bayer-Aktie: Das hört sich nicht gut an...
Bayer Shares Surge After Monsanto Appeal Win
Bayer: Wichtiger Erfolg - Aktie an DAX-Spitze
Aktionäre fordern von Bayer-Chef Anderson mehr Tempo
Compare with SynBiotic SE (SBX)
Bayer-CEO: Werden Wende schaffen - keine schnelle Lösung
Bayer Leverkusen Factfile
'Einfach nur geil': Bayer macht Meisterstück perfekt
See More Headlines
Receive BAYN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
96,931
Year Founded
N/A

Profitability

Net Income
$-2,940,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$47.64 billion
Cash Flow
€5.06 per share
Book Value
€33.52 per share

Miscellaneous

Free Float
N/A
Market Cap
$28.45 billion
Optionable
Not Optionable
Beta
0.97
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. William N. Anderson (Age 58)
    Chairman of the Management Board & CEO
    Comp: $8.43M
  • Mr. Wolfgang U. Nickl (Age 55)
    CFO & Member of Management Board
    Comp: $1.98M
  • Mr. Heiko W. J. Schipper (Age 55)
    Member of Management Board & President of the Consumer Health Division
    Comp: $1.95M
  • Mr. Stefan Oelrich (Age 56)
    Head of the Pharmaceuticals Division & Member of the Board of Management
    Comp: $1.95M
  • Mr. Rodrigo Santos (Age 51)
    Member of Management Board & President of the Crop Science Division
    Comp: $2.17M
  • Ms. Heike Prinz (Age 60)
    Chief Talent Officer, Labor Director & Member of Management Board
    Comp: $1.33M
  • Mr. Julio Triana (Age 58)
    Member of Management Board & President of Consumer Health Division
  • Dr. Sebastian Guth Ph.D.
    Chief Operating Officer
  • Dr. Jost Reinhard (Age 52)
    Head of Investor Relations
  • Mr. Michael Preuss
    Head of Communications, Government Relations and Corporate Brand

BAYN Stock Analysis - Frequently Asked Questions

How have BAYN shares performed in 2024?

Bayer Aktiengesellschaft's stock was trading at €33.63 at the beginning of the year. Since then, BAYN shares have decreased by 13.9% and is now trading at €28.96.
View the best growth stocks for 2024 here
.

Is Bayer Aktiengesellschaft a good dividend stock?

Bayer Aktiengesellschaft (ETR:BAYN) pays an annual dividend of €0.11 per share and currently has a dividend yield of 0.38%.

What other stocks do shareholders of Bayer Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer Aktiengesellschaft investors own include NVIDIA (NVDA), Intel (INTC), Cisco Systems (CSCO), Walt Disney (DIS), Lam Research (LRCX), QUALCOMM (QCOM), SAP (SAP), AbbVie (ABBV), Applied Materials (AMAT) and Advanced Micro Devices (AMD).

This page (ETR:BAYN) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners